Condition
Cutaneous Metastasis
Total Trials
3
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 4 (1)
Trial Status
Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06647342Phase 4RecruitingPrimary
The Effect of Reduced Bleomycin in Electrochemotherapy Treatment
NCT04068155Not ApplicableRecruiting
Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors
NCT03101358Phase 1CompletedPrimary
Study of Topical SOR007 Ointment for Cutaneous Metastases
Showing all 3 trials